Analysis on Current Situation and Ethical Problems of Stem Cell Clinical Research in China
10.12026/j.issn.1001-8565.2022.03.04
- VernacularTitle:我国干细胞临床研究现状与伦理问题分析
- Author:
Qiuju ZHANG
1
;
Jiyin ZHOU
2
;
Hui JIANG
3
Author Information
1. School of Basic Medical, Air Force Medical University, Xi’an 710032, China
2. National Drug Clinical Trial Institution, the Second Affiliated Hospital of Army Medical College, Chongqing 400037, China
3. Scientific and Education Section, Zhangzhou Hospital Affiliated of Fujian Medical University, Zhangzhou 363000, China
- Publication Type:Journal Article
- Keywords:
Stem Cells;
Clinical Research;
Ethical Principles;
Ethics and Law
- From:
Chinese Medical Ethics
2022;35(3):259-262
- CountryChina
- Language:Chinese
-
Abstract:
It is worth pondering how to seek advantages and avoid disadvantages in stem cell clinical research and give full play to the advantages of technology for the benefit of mankind. Through the analysis of the status of stem cell clinical research, including technology and related management methods, proposed the main problems existing in stem cell research, such as the risks of technological uncertainty, ambiguity between research and treatment, over-treatment and technological innovation. Then this paper discussed the ethical and legal risks of stem cell clinical research in China, mainly related to the problems that the construction of laws and regulations is lagging behind, the regulatory challenges of administrative departments are large, the ethical awareness of researchers needs to be further improved, the principle of fairness and justice is not taken into account, the research platform construction of medical institutions is not in place and the protection system of subjects is imperfect, and the organization construction and review capacity of the ethics committee is still lacking.
